US Teen Hospitalized Critically Ill After Viral 'Benadryl Challenge' Attempt

Fifteen-year-old Leah Presson was hospitalized following an attempt at the viral 'Benadryl Challenge'. She was reportedly diagnosed with "zero brain activity" upon her admission, raising concerns about the potential dangers of online trends.

By Fainaron·Jun 16, 2026 (a minute ago)·1 views

US Teen Hospitalized Critically Ill After Viral 'Benadryl Challenge' Attempt

Fifteen-year-old Leah Presson was hospitalized after reportedly attempting the viral 'Benadryl Challenge'. She was diagnosed with "zero brain activity" following the incident.

The hospitalization of the teenager brings attention to the potential severe health risks associated with participation in dangerous online trends.

According to NDTV World, the teen's condition was reported after her attempt at the challenge.

#benadryl challenge #teen health #hospitalization #viral trend #leah presson #brain activity

Source attribution: This article was AI-curated and rewritten by Fainaron from a piece originally published by NDTV World. Read the original at NDTV World →

More like this

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Health

17 minutes ago

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Many individuals prescribed GLP-1 drugs for type 2 diabetes, including medications like Victoza, Ozempic, or tirzepatide, frequently discontinue their use. Researchers have observed that a notable number of these patients later resume treatment. While side effects remain a primary reason for discontinuation, newer GLP-1 medications appear to encourage patients to stay on therapy for longer durations.

Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes Patients

A recent real-world study suggests that semaglutide, known by brand names such as Ozempic, Wegovy, and Rybelsus, may offer an added benefit for individuals with type 2 diabetes. The research indicates that patients using semaglutide experienced fewer bone fractures even while achieving more significant weight loss. The study, which analyzed health records from nearly 60,000 adults, found that those on semaglutide had approximately 15% fewer fractures compared to individuals taking other common weight-loss medications.

Science Daily

U.S. Infant Mortality Reaches All-Time Low in 2025

Health

26 minutes ago

U.S. Infant Mortality Reaches All-Time Low in 2025

Preliminary government data indicates that the infant mortality rate in the United States fell to a new all-time low in 2025, with slightly fewer than 5.4 infant deaths per 1,000 live births. This decline is statistically significant, representing hundreds fewer infant deaths annually. The improvement follows recommendations for new preventative measures introduced in 2023, including antibody shots for infants and RSV vaccines for pregnant women. Despite this progress, the U.S. infant mortality rate remains higher than that of other high-income countries.

Fortune

U.S. Infant Mortality Rate Reaches All-Time Low in 2025

Health

an hour ago

U.S. Infant Mortality Rate Reaches All-Time Low in 2025

Preliminary government data for 2025 indicates that the U.S. infant mortality rate has fallen to a new all-time low. The Centers for Disease Control and Prevention (CDC) reported slightly fewer than 5.4 infant deaths per 1,000 live births. Despite this record low, the U.S. rate continues to trail behind those of other similar nations.

STAT News

Back to Homepage

US Teen Hospitalized Critically Ill After Viral 'Benadryl Challenge' Attempt

More like this

Many Patients Stop GLP-1 Drugs for Type 2 Diabetes But Often Return to Treatment

Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes Patients

U.S. Infant Mortality Reaches All-Time Low in 2025

U.S. Infant Mortality Rate Reaches All-Time Low in 2025

Fainaron — live counters